Logo image of ZIMV

ZIMVIE INC (ZIMV) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ZIMV - US98888T1079 - Common Stock

18.99 USD
0 (0%)
Last: 10/17/2025, 8:00:02 PM
19 USD
+0.01 (+0.05%)
After Hours: 10/17/2025, 8:00:02 PM
Fundamental Rating

4

Overall ZIMV gets a fundamental rating of 4 out of 10. We evaluated ZIMV against 188 industry peers in the Health Care Equipment & Supplies industry. ZIMV has an average financial health and profitability rating. ZIMV is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year ZIMV was profitable.
ZIMV had a positive operating cash flow in the past year.
In the past 5 years ZIMV always reported negative net income.
ZIMV had a positive operating cash flow in each of the past 5 years.
ZIMV Yearly Net Income VS EBIT VS OCF VS FCFZIMV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M

1.2 Ratios

With a decent Return On Assets value of -2.57%, ZIMV is doing good in the industry, outperforming 67.89% of the companies in the same industry.
The Return On Equity of ZIMV (-4.72%) is better than 68.42% of its industry peers.
The Return On Invested Capital of ZIMV (0.77%) is better than 66.84% of its industry peers.
Industry RankSector Rank
ROA -2.57%
ROE -4.72%
ROIC 0.77%
ROA(3y)-13.32%
ROA(5y)-10.87%
ROE(3y)-37.08%
ROE(5y)-25.96%
ROIC(3y)N/A
ROIC(5y)N/A
ZIMV Yearly ROA, ROE, ROICZIMV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

The Operating Margin of ZIMV (1.42%) is better than 66.32% of its industry peers.
With a decent Gross Margin value of 65.31%, ZIMV is doing good in the industry, outperforming 70.00% of the companies in the same industry.
In the last couple of years the Gross Margin of ZIMV has remained more or less at the same level.
Industry RankSector Rank
OM 1.42%
PM (TTM) N/A
GM 65.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.03%
GM growth 5Y-1.34%
ZIMV Yearly Profit, Operating, Gross MarginsZIMV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ZIMV is destroying value.
Compared to 1 year ago, ZIMV has more shares outstanding
ZIMV has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ZIMV has an improved debt to assets ratio.
ZIMV Yearly Shares OutstandingZIMV Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ZIMV Yearly Total Debt VS Total AssetsZIMV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

ZIMV has an Altman-Z score of 0.91. This is a bad value and indicates that ZIMV is not financially healthy and even has some risk of bankruptcy.
ZIMV's Altman-Z score of 0.91 is in line compared to the rest of the industry. ZIMV outperforms 49.47% of its industry peers.
The Debt to FCF ratio of ZIMV is 39.31, which is on the high side as it means it would take ZIMV, 39.31 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ZIMV (39.31) is better than 67.89% of its industry peers.
ZIMV has a Debt/Equity ratio of 0.53. This is a neutral value indicating ZIMV is somewhat dependend on debt financing.
ZIMV has a worse Debt to Equity ratio (0.53) than 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 39.31
Altman-Z 0.91
ROIC/WACC0.11
WACC7.06%
ZIMV Yearly LT Debt VS Equity VS FCFZIMV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

ZIMV has a Current Ratio of 2.37. This indicates that ZIMV is financially healthy and has no problem in meeting its short term obligations.
ZIMV has a Current ratio (2.37) which is comparable to the rest of the industry.
ZIMV has a Quick Ratio of 1.60. This is a normal value and indicates that ZIMV is financially healthy and should not expect problems in meeting its short term obligations.
ZIMV has a Quick ratio of 1.60. This is comparable to the rest of the industry: ZIMV outperforms 43.16% of its industry peers.
Industry RankSector Rank
Current Ratio 2.37
Quick Ratio 1.6
ZIMV Yearly Current Assets VS Current LiabilitesZIMV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 135.90% over the past year.
Looking at the last year, ZIMV shows a very negative growth in Revenue. The Revenue has decreased by -50.48% in the last year.
Measured over the past years, ZIMV shows a very negative growth in Revenue. The Revenue has been decreasing by -15.69% on average per year.
EPS 1Y (TTM)135.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)-50.48%
Revenue growth 3Y-23.75%
Revenue growth 5Y-15.69%
Sales Q2Q%13.02%

3.2 Future

The Earnings Per Share is expected to grow by 19.35% on average over the next years. This is quite good.
ZIMV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.42% yearly.
EPS Next Y54.53%
EPS Next 2Y25.74%
EPS Next 3Y19.35%
EPS Next 5YN/A
Revenue Next Year0.03%
Revenue Next 2Y0.64%
Revenue Next 3Y0.42%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ZIMV Yearly Revenue VS EstimatesZIMV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
ZIMV Yearly EPS VS EstimatesZIMV Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 20.64, which indicates a rather expensive current valuation of ZIMV.
Based on the Price/Earnings ratio, ZIMV is valued a bit cheaper than 80.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of ZIMV to the average of the S&P500 Index (26.31), we can say ZIMV is valued slightly cheaper.
ZIMV is valuated rather expensively with a Price/Forward Earnings ratio of 20.02.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ZIMV indicates a somewhat cheap valuation: ZIMV is cheaper than 80.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.59, ZIMV is valued a bit cheaper.
Industry RankSector Rank
PE 20.64
Fwd PE 20.02
ZIMV Price Earnings VS Forward Price EarningsZIMV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ZIMV is valued a bit cheaper than 78.42% of the companies in the same industry.
70.00% of the companies in the same industry are more expensive than ZIMV, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 95.36
EV/EBITDA 16.74
ZIMV Per share dataZIMV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ZIMV's earnings are expected to grow with 19.35% in the coming years.
PEG (NY)0.38
PEG (5Y)N/A
EPS Next 2Y25.74%
EPS Next 3Y19.35%

0

5. Dividend

5.1 Amount

ZIMV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ZIMVIE INC

NASDAQ:ZIMV (10/17/2025, 8:00:02 PM)

After market: 19 +0.01 (+0.05%)

18.99

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)10-29 2025-10-29/amc
Inst Owners90.35%
Inst Owner Change12.58%
Ins Owners2.73%
Ins Owner Change-1789.95%
Market Cap535.52M
Revenue(TTM)443.40M
Net Income(TTM)-19.47M
Analysts48.89
Price Target16.32 (-14.06%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.01%
Min EPS beat(2)21.96%
Max EPS beat(2)26.05%
EPS beat(4)4
Avg EPS beat(4)32.05%
Min EPS beat(4)1.94%
Max EPS beat(4)78.25%
EPS beat(8)6
Avg EPS beat(8)107.43%
EPS beat(12)9
Avg EPS beat(12)152.03%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.92%
Min Revenue beat(2)-3.18%
Max Revenue beat(2)1.35%
Revenue beat(4)1
Avg Revenue beat(4)-1.41%
Min Revenue beat(4)-3.62%
Max Revenue beat(4)1.35%
Revenue beat(8)2
Avg Revenue beat(8)-2.36%
Revenue beat(12)4
Avg Revenue beat(12)-1.34%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)37.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.5%
EPS NY rev (1m)0%
EPS NY rev (3m)7.11%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.3%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.52%
Valuation
Industry RankSector Rank
PE 20.64
Fwd PE 20.02
P/S 1.21
P/FCF 95.36
P/OCF 44.75
P/B 1.3
P/tB 8.91
EV/EBITDA 16.74
EPS(TTM)0.92
EY4.84%
EPS(NY)0.95
Fwd EY5%
FCF(TTM)0.2
FCFY1.05%
OCF(TTM)0.42
OCFY2.23%
SpS15.72
BVpS14.64
TBVpS2.13
PEG (NY)0.38
PEG (5Y)N/A
Graham Number17.41
Profitability
Industry RankSector Rank
ROA -2.57%
ROE -4.72%
ROCE 0.97%
ROIC 0.77%
ROICexc 0.86%
ROICexgc 2.21%
OM 1.42%
PM (TTM) N/A
GM 65.31%
FCFM 1.27%
ROA(3y)-13.32%
ROA(5y)-10.87%
ROE(3y)-37.08%
ROE(5y)-25.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.03%
GM growth 5Y-1.34%
F-Score6
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 39.31
Debt/EBITDA 5.39
Cap/Depr 18.32%
Cap/Sales 1.43%
Interest Coverage 0.43
Cash Conversion 29.2%
Profit Quality N/A
Current Ratio 2.37
Quick Ratio 1.6
Altman-Z 0.91
F-Score6
WACC7.06%
ROIC/WACC0.11
Cap/Depr(3y)17.11%
Cap/Depr(5y)24.69%
Cap/Sales(3y)2.37%
Cap/Sales(5y)3.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)135.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y54.53%
EPS Next 2Y25.74%
EPS Next 3Y19.35%
EPS Next 5YN/A
Revenue 1Y (TTM)-50.48%
Revenue growth 3Y-23.75%
Revenue growth 5Y-15.69%
Sales Q2Q%13.02%
Revenue Next Year0.03%
Revenue Next 2Y0.64%
Revenue Next 3Y0.42%
Revenue Next 5YN/A
EBIT growth 1Y126.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year148.72%
EBIT Next 3Y45.39%
EBIT Next 5YN/A
FCF growth 1Y117.33%
FCF growth 3Y-0.91%
FCF growth 5Y-35.32%
OCF growth 1Y192.13%
OCF growth 3Y-39.59%
OCF growth 5Y-34.68%

ZIMVIE INC / ZIMV FAQ

Can you provide the ChartMill fundamental rating for ZIMVIE INC?

ChartMill assigns a fundamental rating of 4 / 10 to ZIMV.


Can you provide the valuation status for ZIMVIE INC?

ChartMill assigns a valuation rating of 5 / 10 to ZIMVIE INC (ZIMV). This can be considered as Fairly Valued.


What is the profitability of ZIMV stock?

ZIMVIE INC (ZIMV) has a profitability rating of 4 / 10.


What is the valuation of ZIMVIE INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ZIMVIE INC (ZIMV) is 20.64 and the Price/Book (PB) ratio is 1.3.


Can you provide the dividend sustainability for ZIMV stock?

The dividend rating of ZIMVIE INC (ZIMV) is 0 / 10 and the dividend payout ratio is 0%.